Section Arrow
Quote
ALGN.NASDAQ
- Align Technology
Quotes are at least 15-min delayed:2024/05/15 02:32 EDT
Last
 278.08
+5.34 (+1.96%)
Day High 
281.4 
Prev. Close
272.74 
1-M High
327.49 
Volume 
455.03K 
Bid
271
Ask
278.7
Day Low
273.62 
Open
274.63 
1-M Low
263.99 
Market Cap 
20.53B 
Currency USD 
P/E 46.94 
%Yield 0 
10-SMA 281.37 
20-SMA 293.5 
50-SMA 307.41 
52-W High 413.2 
52-W Low 176.34 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
5.81/10.96
Enterprise Value
20.63B
Balance Sheet
Book Value Per Share
49.94
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
3.86B
Operating Revenue Per Share
50.57
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SINTSiNtx Technologies0.055+0.0162+41.75%-- 
PACBPacific Biosciences of California2.23+0.3+15.54%-- 
ZOMZomedica Corp0.1461+0.0064+4.58%-- 
ABTAbbott Laboratories104.01-0.76-0.73%32.14PE
CATXPerspective Therapeutics1.76+0.02+1.15%-- 
Quotes are at least 15-min delayed：2024/05/15 02:32 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.